Chase AIPricingFAQs
Display currency
Loading news…

Origo Biopharma

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
San Ciprián De Viñas, Galicia, Spain Founded 2017 1-10 employees For Profit

Origo Biopharma is a biotech company.

Origo Biopharma was acquired by AgomAb Therapeutics in 2021.
Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
0
Monthly Visits
Available in Pro
Contacts
0
Patents
2
1 trademarks

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Private

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
6
Patents granted
2
Trademarks
1
Top patent class
Organic Chemistry
IT spend
$9M

Company Info

Founded
2017
Employees
1-10
Operating status
Active
Company type
For Profit
Org types
company
Founders
1
News articles
4
HQ
San Ciprián De Viñas, Galicia, Spain
Region
European Union (EU), Europe, Middle East, and Africa (EMEA)
Exit date
Oct 28, 2021

Signals & Scores

Heat score
Low
Growth score
Low
Trend (7d)
0
Trend (30d)
-0.1
Trend (90d)
-0.7

Key People at Origo Biopharma

Co-founder

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to Origo Biopharma

Loading news…

FAQs about Origo Biopharma

People who checked this page also checked these

Browse the full Acquirezy directory.
Origo Biopharma - Company Profile, Full Acquisitions List, Funding and Investments